Cancer
Cancer/Malignancies
ICAAC 2013: Raltegravir Safest for HIV+ Patients on Cancer Chemotherapy
- Details
- Category: Cancer/Malignancies
- Published on Friday, 13 September 2013 00:00
- Written by Liz Highleyman
The integrase inhibitor raltegravir (Isentress) may be an optimal choice for many HIV positive people undergoing cancer chemotherapy, as it is highly effective and well-tolerated in this population, according to a poster presentation at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) this week in Denver.
Recent Studies Shed Light on Cancer Among People with HIV
- Details
- Category: Cancer/Malignancies
- Published on Tuesday, 03 September 2013 00:00
- Written by Liz Highleyman
Starting antiretroviral therapy (ART) with a low CD4 count raises the likelihood of certain cancers, but others increase with longer time on therapy, reflecting a rising risk associated with older age, according to a recently published study. Other new research revealed increases in malignancies related to viral infections and a higher risk of Kaposi sarcoma even after immune restoration.
CROI 2013: Random Anal Biopsies Improve Detection of Pre-cancerous Lesions
- Details
- Category: HIV-Related Conditions
- Published on Wednesday, 10 April 2013 00:00
- Written by Matt Sharp
Performing random anal biopsies increases the rate of diagnosis of high-grade squamous intraepithelial lesions (HSIL) during high-resolution anoscopy, researchers from Mt. Sinai School of Medicine in New York City reported at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013).
IAS 2013: People with HIV Who Use Statins May Have Lower Cancer Risk
- Details
- Category: Cancer/Malignancies
- Published on Wednesday, 14 August 2013 00:00
- Written by Liz Highleyman
HIV positive people who use statins to manage high cholesterol also may reduce their risk of developing non-AIDS-defining malignancies, according to study findings reported at the recent 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.
CROI 2013: Researchers Look at Neurological Complications among People with HIV
- Details
- Category: HIV-Related Conditions
- Published on Monday, 25 March 2013 00:00
- Written by Matt Sharp
Data from a small, yet well-designed trial to evaluate whether particular antiretroviral therapy (ART) regimens penetrate the central nervous system (CNS) and enhance neurocognitive performance were among several interesting findings regarding neurological complications among people with HIV presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta. Another study looked at similarities between Alzheimer's disease and neurocognitive impairment in people with HIV.
More Articles...
- CROI 2013: Statins for People with HIV -- How Sweet Is It?
- CROI 2013: HIV and Aging -- Are People with HIV at Greater Risk for Heart Disease and Cancer? [VIDEO]
- CROI 2013: HIV+ Men at Increased Risk for Co-morbid Conditions Regardless of Age
- CROI 2013: Cancer Incidence After Starting Antiretroviral Therapy [VIDEO]
Web Design and Development by